Prescription ID | TCMF3358 |
Pinyin Name | Bao Ji Wan |
Chinese Name | 保济丸 |
English Name | Bao Ji Pills |
Function Description | 腹痛, 腹泻, 晕动病, 感冒 |
Indications | Abdominal pain disorder, Common cold disorder, Dyspepsia, Enteritis, Diarrhea, Common cold, Motion sickness |
Disease ICD-11 Category |
SA58 [Abdominal pain disorder (TM1), 腹痛 (TM1)
]; SA60 [Common cold disorder (TM1), 感冒 (TM1) ]; MD92 [Dyspepsia, 消化不良 ]; 1A40.Z [Infectious gastroenteritis or colitis without specification of infectious agent, 未特指感染性病原体的感染性胃肠炎或结肠炎 ]; ME05.1 [Diarrhoea, 腹泻 ]; CA00 [Acute nasopharyngitis, 急性鼻咽炎 ]; NF08.3 [Motion sickness, 晕动病 ]; |
Human Tissues Associated with Indication | Lung, Intestine, Stomach, Blood |
Reference | CFDA |
Reference Book/link | http://samr.cfda.gov.cn/WS01/CL0001/ |
Component ID | Latin Name | Chinese Name | Component Quantity | Barcode |
---|---|---|---|---|
TCMH695 | Uncaria rhynchophylla | 钩藤 | TCMH695 | ITSAM939-14 |
TCMH1181 | Chrysanthemum morifolium | 菊花 | TCMH1181 | KX675020 |
TCMH1024 | Tribulus terrestris | 蒺藜 | TCMH1024 | ITSAJ4258-14 |
TCMH890 | Cortex magnoliae officinalis | 厚朴 | TCMH890 | ITSAM1591-14 |
TCMH1533 | Saussurea lappa | 木香 | TCMH1533 | |
TCMH211 | Atractylodes lancea | 苍术 | TCMH211 | ITSAN4439-14 |
TCMH2086 | Trichosanthes kirilowii | 天花粉 | TCMH2086 | ITSAO4359-14 |
TCMH728 | Pogostemon cablin | 广藿香 | TCMH728 | ITSAJ4146-14 |
TCMH677 | Pueraria lobata | 葛根 | TCMH677 | ITSAJ4206-14 |
TCMH606 | Wolfiporia cocos | 茯苓 | TCMH606 | GBPOL314-13 |
TCMH188 | Mentha haplocalyx | 薄荷 | TCMH188 | HM595443 |
TCMH925 | Exocarpium citri grandis | 化橘红 | TCMH925 | |
TCMH118 | Angelica dahurica | 白芷 | TCMH118 | ITSAK3312-14 |
TCMH2486 | Coix lacryma- jobi var. ma - yuen | 薏苡仁 | TCMH2486 | |
TCMH1307 | Massa medicata fermentata | 六神曲 | TCMH1307 | |
TCMH1430 | Hordeum vulgare | 麦芽 | TCMH1430 | ITSAI3101-14 |
TCMH1848 | Crataegus pinnatifida | 山楂 | TCMH1848 | ITSAH1684-14 |
TCMH2265 | Cyperus rotundus | 香附 | TCMH2265 | GENG1049-15 |
TCMH243 | Pericarpium citri reticulatae | 陈皮 | TCMH243 | |
TCMH2722 | Perilla frutescens var. arguta | 紫苏叶 | TCMH2722 | ITSAF2620-14 |
TCMH182 | Areca catechu | 槟榔 | TCMH182 | ITSAA732-14 |
TCMH1080 | Platycodon grandiflorum | 桔梗 | TCMH1080 | ITSAJ4293-14 |
TCMH130 | Pinellia ternata | 半夏 | TCMH130 | GBVT1123-13, GBVY1693-14 |
TCMH1803 | Amomum villosum | 砂仁 | TCMH1803 | ITSAD521-14 |
TCMH512 | Fructus amomi rotundus | 豆蔻 | TCMH512 | |
TCMH628 | Glycyrrhiza uralensis | 甘草 | TCMH628 | ITSAM892-14 |
TCMH436 | Fructus oryzae germinatus | 稻芽 | TCMH436 |
Target ID | Gene Symbol | Target Name | Target Class | Uniprot ID |
---|---|---|---|---|
TCMT100 | TTR | Transthyretin | Unclassified | P02766 |
TCMT101 | PTPN1 | Protein-tyrosine phosphatase 1B | Hydrolase | P18031 |
TCMT102 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | Hydrolase | P24666 |
TCMT103 | PTPRF | Receptor-type tyrosine-protein phosphatase F (LAR) | Hydrolase | P10586 |
TCMT112 | ADORA3 | Adenosine A3 receptor | GPCR | P0DMS8 |
TCMT114 | CNR2 | Cannabinoid CB2 receptor | GPCR | P34972 |
TCMT115 | CNR1 | Cannabinoid CB1 receptor | GPCR | P21554 |
TCMT127 | PARP1 | Poly [ADP-ribose] polymerase-1 | Transferase | P09874 |
TCMT128 | TNKS2 | Tankyrase-2 | Transferase | Q9H2K2 |
TCMT129 | TNKS | Tankyrase-1 | Transferase | O95271 |
TCMT13 | APEX1 | DNA-(apurinic or apyrimidinic site) lyase | Lyase | P27695 |
TCMT130 | ALOX5 | Arachidonate 5-lipoxygenase | Oxidoreductase | P09917 |
TCMT131 | ACHE | Acetylcholinesterase | Hydrolase | P22303 |
TCMT133 | CA1 | Carbonic anhydrase I | Lyase | P00915 |
TCMT134 | CA2 | Carbonic anhydrase II | Lyase | P00918 |
TCMT135 | CA14 | Carbonic anhydrase XIV | Lyase | Q9ULX7 |
TCMT136 | CA12 | Carbonic anhydrase XII | Lyase | O43570 |
TCMT137 | CA9 | Carbonic anhydrase IX | Lyase | Q16790 |
TCMT138 | CA7 | Carbonic anhydrase VII | Lyase | P43166 |
TCMT139 | CA6 | Carbonic anhydrase VI | Lyase | P23280 |
TCMT140 | CA5B | Carbonic anhydrase VB | Lyase | Q9Y2D0 |
TCMT141 | CA5A | Carbonic anhydrase VA | Lyase | P35218 |
TCMT142 | CA4 | Carbonic anhydrase IV | Lyase | P22748 |
TCMT143 | CA3 | Carbonic anhydrase III | Lyase | P07451 |
TCMT150 | RORC | Nuclear receptor ROR-gamma | Nuclear receptor | P51449 |
TCMT156 | CYP19A1 | Cytochrome P450 19A1 | Oxidoreductase | P11511 |
TCMT159 | TYR | Tyrosinase | Oxidoreductase | P14679 |
TCMT161 | HCAR2 | Hydroxycarboxylic acid receptor 2 | GPCR | Q8TDS4 |
TCMT162 | UGT1A1 | UDP-glucuronosyltransferase 1-1 | Transferase | P22309 |
TCMT174 | HSD11B1 | 11-beta-hydroxysteroid dehydrogenase 1 | Oxidoreductase | P28845 |
TCMT190 | PTPN2 | T-cell protein-tyrosine phosphatase | Hydrolase | P17706 |
TCMT2 | MAPT | Microtubule-associated protein tau | Unclassified | P10636 |
TCMT208 | MAOA | Monoamine oxidase A | Oxidoreductase | P21397 |
TCMT209 | HSD11B2 | 11-beta-hydroxysteroid dehydrogenase 2 | Oxidoreductase | P80365 |
TCMT212 | SRC | Tyrosine-protein kinase SRC | Kinase | P12931 |
TCMT215 | CYP1A1 | Cytochrome P450 1A1 | Oxidoreductase | P04798 |
TCMT217 | CYP2C8 | Cytochrome P450 2C8 | Oxidoreductase | P10632 |
TCMT219 | CYP1A2 | Cytochrome P450 1A2 | Oxidoreductase | P05177 |
TCMT223 | AKR1B1 | Aldose reductase | Oxidoreductase | P15121 |
TCMT23 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | Hydrolase | P05186 |
TCMT231 | GBA2 | Beta-glucosidase | Hydrolase | Q9HCG7 |
TCMT236 | ESR2 | Estrogen receptor beta | Nuclear receptor | Q92731 |
TCMT239 | PIM1 | Serine/threonine-protein kinase PIM1 | Kinase | P11309 |
TCMT249 | CDK6 | Cyclin-dependent kinase 6 | Kinase | Q00534 |
TCMT254 | CBR1 | Carbonyl reductase [NADPH] 1 | Oxidoreductase | P16152 |
TCMT257 | CYP1B1 | Cytochrome P450 1B1 | Oxidoreductase | Q16678 |
TCMT260 | FLT3 | Tyrosine-protein kinase receptor FLT3 | Kinase | P36888 |
TCMT261 | DAPK1 | Death-associated protein kinase 1 | Kinase | P53355 |
TCMT27 | DRD1 | Dopamine D1 receptor | GPCR | P21728 |
TCMT280 | AKR1B10 | Aldo-keto reductase family 1 member B10 | Oxidoreductase | O60218 |
TCMT289 | TBXAS1 | Thromboxane-A synthase | Isomerase | P24557 |
TCMT292 | CHRM1 | Muscarinic acetylcholine receptor M1 | GPCR | P11229 |
TCMT293 | CHRM2 | Muscarinic acetylcholine receptor M2 | GPCR | P08172 |
TCMT295 | MMP1 | Matrix metalloproteinase-1 | Hydrolase | P03956 |
TCMT296 | ADORA1 | Adenosine A1 receptor | GPCR | P30542 |
TCMT297 | FABP4 | Fatty acid binding protein adipocyte | Unclassified | P15090 |
TCMT298 | FABP3 | Fatty acid binding protein muscle | Hydrolase | P05413 |
TCMT30 | PTGS2 | Cyclooxygenase-2 | Oxidoreductase | P35354 |
TCMT302 | HMGCR | HMG-CoA reductase | Oxidoreductase | P04035 |
TCMT306 | MMP2 | Matrix metalloproteinase-2 | Hydrolase | P08253 |
TCMT315 | HTR6 | Serotonin 6 (5-HT6) receptor | GPCR | P50406 |
TCMT321 | MMP9 | Matrix metalloproteinase 9 | Hydrolase | P14780 |
TCMT322 | MMP13 | Matrix metalloproteinase 13 | Hydrolase | P45452 |
TCMT335 | MPO | Myeloperoxidase | Oxidoreductase | P05164 |
TCMT336 | IDO1 | Indoleamine 2,3-dioxygenase | Oxidoreductase | P14902 |
TCMT337 | XPO1 | Exportin-1 | Unclassified | O14980 |
TCMT344 | AOX1 | Aldehyde oxidase | Oxidoreductase | Q06278 |
TCMT355 | CSNK1D | Casein kinase I delta | Kinase | P48730 |
TCMT369 | IGF1R | Insulin-like growth factor I receptor | Kinase | P08069 |
TCMT370 | KDR | Vascular endothelial growth factor receptor 2 | Kinase | P35968 |
TCMT374 | AURKB | Serine/threonine-protein kinase Aurora-B | Kinase | Q96GD4 |
TCMT38 | DRD2 | Dopamine D2 receptor | GPCR | P14416 |
TCMT388 | AXL | Tyrosine-protein kinase receptor UFO | Kinase | P30530 |
TCMT401 | MET | Hepatocyte growth factor receptor | Kinase | P08581 |
TCMT417 | DYRK2 | Dual-specificity tyrosine-phosphorylation regulated kinase 2 | Kinase | Q92630 |
TCMT422 | CAMK2B | CaM kinase II beta | Kinase | Q13554 |
TCMT44 | GLO1 | Glyoxalase I | Lyase | Q04760 |
TCMT445 | NEK2 | Serine/threonine-protein kinase NEK2 | Kinase | P51955 |
TCMT458 | HASPIN | Serine/threonine-protein kinase haspin | Kinase | Q8TF76 |
TCMT46 | F3 | Coagulation factor III | Unclassified | P13726 |
TCMT462 | NEK6 | Serine/threonine-protein kinase NEK6 | Kinase | Q9HC98 |
TCMT47 | BCL2 | Apoptosis regulator Bcl-2 | Ion channel | P10415 |
TCMT473 | PIM3 | Serine/threonine-protein kinase PIM3 | Kinase | Q86V86 |
TCMT479 | AKT1 | Serine/threonine-protein kinase AKT | Kinase | P31749 |
TCMT484 | PLK1 | Serine/threonine-protein kinase PLK1 | Kinase | P53350 |
TCMT506 | PTK2B | Protein tyrosine kinase 2 beta | Kinase | Q14289 |
TCMT551 | CHRM4 | Muscarinic acetylcholine receptor M4 | GPCR | P08173 |
TCMT558 | TOP2A | DNA topoisomerase II alpha | Isomerase | P11388 |
TCMT563 | CDC25B | Dual specificity phosphatase Cdc25B | Hydrolase | P30305 |
TCMT571 | ADORA2B | Adenosine A2b receptor | GPCR | P29275 |
TCMT591 | ESRRA | Estrogen-related receptor alpha | Nuclear receptor | P11474 |
TCMT592 | XDH | Xanthine dehydrogenase | Oxidoreductase | P47989 |
TCMT597 | SLC28A3 | Solute carrier family 28 member 3 | Transporter | Q9HAS3 |
TCMT599 | UBE2N | Ubiquitin-conjugating enzyme E2 N | Transferase | P61088 |
TCMT614 | EGLN1 | Egl nine homolog 1 | Oxidoreductase | Q9GZT9 |
TCMT63 | PPARA | Peroxisome proliferator-activated receptor alpha | Nuclear receptor | Q07869 |
TCMT637 | SIRT3 | NAD-dependent deacetylase sirtuin 3 | Hydrolase | Q9NTG7 |
TCMT638 | SIRT2 | NAD-dependent deacetylase sirtuin 2 | Hydrolase | Q8IXJ6 |
TCMT65 | HSD17B1 | Estradiol 17-beta-dehydrogenase 1 | Oxidoreductase | P14061 |
TCMT66 | HSD17B2 | Estradiol 17-beta-dehydrogenase 2 | Oxidoreductase | P37059 |
TCMT709 | SLC28A2 | Sodium/nucleoside cotransporter 2 | Transporter | O43868 |
TCMT710 | SLC28A1 | Sodium/nucleoside cotransporter 1 | Transporter | O00337 |
TCMT734 | MMP12 | Matrix metalloproteinase 12 | Hydrolase | P39900 |
TCMT737 | APOBEC3G | DNA dC->dU-editing enzyme APOBEC-3G | Unclassified | Q9HC16 |
TCMT740 | PIK3CG | PI3-kinase p110-gamma subunit | Transferase | P48736 |
TCMT747 | ABCG2 | ATP-binding cassette sub-family G member 2 | Transporter | Q9UNQ0 |
TCMT751 | DYRK1A | Dual-specificity tyrosine-phosphorylation regulated kinase 1A | Kinase | Q13627 |
TCMT752 | CSNK2A1 | Casein kinase II alpha | Kinase | P68400 |
TCMT763 | DYRK3 | Dual-specificity tyrosine-phosphorylation regulated kinase 3 | Kinase | O43781 |
TCMT784 | AVPR2 | Vasopressin V2 receptor | GPCR | P30518 |
TCMT785 | CXCR1 | Interleukin-8 receptor A | GPCR | P25024 |
TCMT786 | CCR4 | C-C chemokine receptor type 4 | GPCR | P51679 |
TCMT791 | PKN1 | Protein kinase N1 | Kinase | Q16512 |
TCMT793 | PYGL | Liver glycogen phosphorylase | Transferase | P06737 |
TCMT8 | KDM4E | Lysine-specific demethylase 4D-like | Oxidoreductase | B2RXH2 |
TCMT807 | SLC22A12 | Solute carrier family 22 member 12 | Transporter | Q96S37 |
TCMT808 | FABP5 | Fatty acid binding protein epidermal | Unclassified | Q01469 |
TCMT809 | FABP2 | Fatty acid binding protein intestinal | Unclassified | P12104 |
TCMT810 | TLR2 | Toll-like receptor 2 | Unclassified | O60603 |
TCMT814 | CLK1 | Dual specificty protein kinase CLK1 | Kinase | P49759 |
TCMT82 | ESR1 | Estrogen receptor alpha | Nuclear receptor | P03372 |
TCMT822 | FUT7 | Alpha-(1,3)-fucosyltransferase 7 | Transferase | Q11130 |
TCMT829 | NISCH | Nischarin | Unclassified | Q9Y2I1 |
TCMT83 | CD38 | Lymphocyte differentiation antigen CD38 | Unclassified | P28907 |
TCMT831 | DYRK4 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 | Kinase | Q9NR20 |
TCMT832 | DYRK1B | Dual specificity tyrosine-phosphorylation-regulated kinase 1B | Kinase | Q9Y463 |
TCMT87 | CYP2C9 | Cytochrome P450 2C9 | Oxidoreductase | P11712 |
TCMT884 | PHF8 | Histone lysine demethylase PHF8 | Oxidoreductase | Q9UPP1 |
TCMT910 | ESRRB | Estrogen-related receptor beta | Nuclear receptor | O95718 |
TCMT965 | KDM7A | Lysine-specific demethylase 7 | Oxidoreductase | Q6ZMT4 |
Target ID | Target Name |
---|---|
TCMT1170 | Enterobacter cloacae |
TCMT1172 | Staphylococcus aureus subsp. aureus RN4220 |
TCMT1174 | Mycobacterium bovis BCG |
TCMT1175 | Human immunodeficiency virus |
TCMT1176 | Streptococcus pneumoniae |
TCMT1177 | Haemophilus influenzae |
TCMT1178 | Actinomyces viscosus |
TCMT1179 | Escherichia coli ATCC 8739 |
TCMT1180 | Human herpesvirus 2 |
TCMT1181 | Mycobacterium tuberculosis H37Ra |
TCMT1182 | Streptococcus sanguinis |
TCMT1183 | Candida albicans SC5314 |
TCMT1184 | Mycobacterium fortuitum |
TCMT1185 | Mycobacterium phlei |
TCMT1186 | Plasmodium yoelii yoelii |
TCMT1187 | Enterococcus faecalis ATCC 29212 |
TCMT1189 | Pseudomonas fluorescens |
TCMT1191 | Bacillus megaterium |
TCMT1192 | Bacteria |
TCMT1193 | Staphylococcus |
TCMT1194 | Shigella sonnei |
TCMT1196 | Salmonella |
TCMT1198 | Serratia marcescens |
TCMT1199 | Streptococcus sp. 'group A' |
TCMT1200 | Bacillus thuringiensis |
TCMT1201 | Staphylococcus epidermidis ATCC 12228 |
TCMT1202 | Mycoplasma hominis |
TCMT1203 | Mycoplasma pneumoniae |
TCMT1204 | Clostridium perfringens |
TCMT1207 | Legionella pneumophila |
TCMT1208 | Escherichia coli K12 |
TCMT1209 | Staphylococcus haemolyticus |
TCMT1210 | Streptococcus sobrinus |
TCMT1211 | Fusobacterium nucleatum |
TCMT1212 | Verticillium dahliae |
TCMT1213 | Neisseria gonorrhoeae |
TCMT1214 | Enterococcus faecium |
TCMT1215 | Pseudomonas aeruginosa PAO1 |
TCMT1216 | Vibrio cholerae |
TCMT1217 | Bacillus anthracis |
TCMT1218 | Staphylococcus aureus |
TCMT1219 | Enterococcus |
TCMT1220 | Streptococcus pneumoniae R6 |
TCMT1221 | Human herpesvirus 4 |
TCMT1222 | Plasmodium falciparum D6 |
TCMT1223 | Staphylococcus epidermidis |
TCMT1224 | Proteus mirabilis |
TCMT1226 | Klebsiella pneumoniae |
TCMT1227 | Streptococcus |
TCMT1229 | Enterococcus faecalis |
TCMT1232 | Pseudomonas aeruginosa |
TCMT1234 | Bacillus coagulans |
TCMT1235 | Clostridium sporogenes |
TCMT1236 | Mycobacterium bovis |
TCMT1237 | Mycobacterium kansasii |
TCMT1238 | Mycobacterium xenopi |
TCMT1239 | Mycobacterium marinum |
TCMT1243 | Aspergillus flavus |
TCMT1244 | Staphylococcus saprophyticus |
TCMT1245 | Phytophthora cactorum |
TCMT1246 | Escherichia coli |
TCMT1247 | Human herpesvirus 1 |
TCMT1248 | Hepatitis C virus |
TCMT1249 | Dengue virus 2 |
TCMT1251 | Candida albicans |
TCMT1252 | Alcaligenes faecalis |
TCMT1253 | Penicillium chrysogenum |
TCMT1255 | Human immunodeficiency virus 1 |
TCMT1260 | Streptococcus agalactiae |
TCMT1262 | Mycoplasma putrefaciens |
TCMT1266 | Mycobacterium abscessus |
TCMT1267 | Mycobacterium chelonae |
TCMT1271 | Shigella flexneri |
TCMT1272 | Campylobacter jejuni |
TCMT1273 | Pseudomonas putida |
TCMT1274 | Shigella boydii |
TCMT1276 | Klebsiella |
TCMT1277 | Serratia |
TCMT1278 | Pseudomonas |
TCMT1281 | Clostridium difficile |
TCMT1284 | Penicillium expansum |
TCMT1286 | Bacillus cereus |
TCMT1287 | Bacillus subtilis subsp. spizizenii ATCC 6633 |
TCMT1289 | Shigella dysenteriae |
TCMT1290 | Acinetobacter calcoaceticus |
TCMT1291 | Haemophilus parainfluenzae |
TCMT1294 | Human parainfluenza virus 3 |
TCMT1296 | Influenza A virus H3N2 |
TCMT1299 | Morganella morganii |
TCMT1300 | Enterobacter |
TCMT1301 | Klebsiella sp. |
TCMT1303 | Bacillus |
TCMT1304 | Staphylococcus capitis |
TCMT1305 | Salmonella enteritidis |
TCMT1307 | Penicillium marneffei |
TCMT1309 | Aspergillus clavatus |
TCMT1310 | Enterococcus hirae |
TCMT1314 | Streptococcus viridans |
TCMT1315 | Streptococcus sp. |
TCMT1317 | Staphylococcus lentus |
TCMT1318 | Human T-lymphotropic virus 1 |
TCMT1321 | Staphylococcus hominis |
TCMT1322 | Streptococcus mitis |
TCMT1326 | Shigella |
TCMT1331 | Acinetobacter sp. |
TCMT1332 | Bacillus licheniformis |
TCMT1334 | Chlamydia trachomatis |
TCMT1340 | Staphylococcus faecalis |
TCMT1341 | Streptococcus oralis |
TCMT1342 | Streptococcus salivarius |
TCMT1343 | Staphylococcus simulans |
TCMT1344 | Staphylococcus sciuri |
TCMT1345 | Prevotella loescheii |
TCMT1346 | Helicobacter pylori |
TCMT1349 | Helicobacter pylori SS1 |
TCMT1353 | Plasmodium yoelii |
TCMT1354 | Streptococcus mutans UA159 |
TCMT1355 | Rhodococcus equi |
TCMT1356 | Campylobacter coli |
TCMT1358 | Bacteroides vulgatus |
TCMT1361 | Neisseria meningitidis |
TCMT1362 | Bordetella pertussis |
TCMT1363 | Peptostreptococcus anaerobius |
TCMT1366 | Prevotella bivia |
TCMT1370 | Prevotella melaninogenica |
TCMT1371 | Veillonella parvula |
TCMT1375 | Clostridium tetani |
TCMT1377 | Staphylococcus lugdunensis |
TCMT1378 | Acinetobacter haemolyticus |
TCMT1381 | Listeria innocua |
TCMT1382 | Plasmodium falciparum (isolate K1 / Thailand) |
TCMT1383 | Streptomyces griseus |
TCMT1388 | Prevotella disiens |
TCMT1389 | Klebsiella oxytoca |
TCMT1393 | Vibrio sp. |
TCMT1394 | Mycobacterium aurum |
TCMT1395 | Staphylococcus sp. |
TCMT1396 | Fusobacterium |
TCMT1399 | Chlamydophila pneumoniae |
TCMT1400 | Mycobacterium mageritense |
TCMT1401 | Staphylococcus warneri |
TCMT1402 | Staphylococcus cohnii |
TCMT1403 | Streptococcus constellatus |
TCMT1404 | Streptococcus intermedius |
TCMT1406 | Mycobacterium leprae |
TCMT1407 | Aeromonas punctata |
TCMT1408 | Colletotrichum gloeosporioides |
TCMT1409 | Escherichia coli O157:H7 |
TCMT1410 | Listeria monocytogenes |
TCMT1411 | Vibrio parahaemolyticus |
TCMT1412 | Salmonella typhimurium |
TCMT1413 | Vibrio splendidus |
TCMT1414 | Vibrio vulnificus |
TCMT1415 | Vibrio fluvialis |
TCMT1416 | Plesiomonas shigelloides |
TCMT1417 | Aeromonas sobria |
TCMT1418 | Enterobacteriaceae |
TCMT1420 | Klebsiella pneumoniae subsp. ozaenae |
TCMT1421 | Vibrio mimicus |
TCMT1422 | Clostridium histolyticum |
TCMT1423 | Peptostreptococcus |
TCMT1424 | Haemophilus ducreyi |
TCMT1425 | Moraxella bovis |
TCMT1427 | Proteus inconstans |
TCMT1429 | Acinetobacter pittii |
TCMT1431 | Coxiella burnetii |
TCMT1432 | Serratia sp. |
TCMT1434 | Plesiomonas |
TCMT1435 | Corynebacterium |
TCMT1438 | Plasmodium falciparum |
TCMT1439 | Mycobacterium smegmatis |
TCMT1442 | Leishmania donovani |
TCMT1443 | Leishmania amazonensis |
TCMT1444 | Fusarium oxysporum |
TCMT1447 | Respiratory syncytial virus |
TCMT1448 | Enterobacter aerogenes |
TCMT1449 | Influenza A virus |
TCMT1450 | Plasmodium falciparum 3D7 |
TCMT1454 | Bacillus subtilis |
TCMT1455 | Mycobacterium tuberculosis H37Rv |
TCMT1457 | Leishmania major |
TCMT1458 | Filobasidiella neoformans |
TCMT1460 | Mycobacterium intracellulare |
TCMT1462 | Streptococcus mutans |
TCMT1463 | Mycobacterium tuberculosis |
TCMT1464 | Hepatitis B virus |
TCMT1465 | Entamoeba histolytica |
GO Term | GO Name | Enriched Genes | Log10 Adjusted P-value |
---|---|---|---|
[BP] GO:0015701 | bicarbonate transport | CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 | 12.6235 |
[BP] GO:1901700 | response to oxygen-containing compound | AKR1B1, ALPL, APEX1, AXL, BCL2, CA3, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FABP3, HMGCR, HSD11B2, HSD17B2, IDO1, IGF1R, MMP2, MMP9, MPO, PPARA, PTGS2, RORC, SRC, TYR | 12.026 |
[BP] GO:0006730 | one-carbon metabolic process | CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 | 11.8393 |
[BP] GO:0008152 | metabolic process | ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CDK6, CHRM1, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HASPIN, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, MAOA, MET, MMP1, MMP12, MMP2, MMP9, MPO, NISCH, PHF8, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TBXAS1, TNKS, TNKS2, TOP2A, TYR, XDH | 11.6363 |
[BP] GO:0044281 | small molecule metabolic process | ABCG2, AKR1B1, AKR1B10, ALOX5, AOX1, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FUT7, GBA2, GLO1, HMGCR, IDO1, MPO, NISCH, PIM1, PPARA, PTGS2, TBXAS1, TYR, XDH | 10.3727 |
[BP] GO:0033993 | response to lipid | ALPL, AXL, BCL2, CA2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, IDO1, MPO, PTGS2, RORC, SRC, TYR | 9.89285 |
[BP] GO:0010033 | response to organic substance | AKR1B1, ALPL, APEX1, AXL, BCL2, CA2, CA3, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FABP3, FABP4, FLT3, HMGCR, HSD11B2, HSD17B2, IDO1, IGF1R, KDR, MMP2, MPO, PPARA, PTGS2, RORC, SRC, TYR | 9.37642 |
[BP] GO:0044237 | cellular metabolic process | ABCG2, ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CDK6, CHRM1, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HASPIN, HMGCR, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, MAOA, MET, MMP1, MMP2, MPO, PHF8, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TBXAS1, TNKS, TNKS2, TOP2A, TYR, XDH | 8.53017 |
[BP] GO:0042221 | response to chemical | ABCG2, AKR1B1, ALPL, APEX1, AXL, BCL2, CA2, CA3, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FABP3, FABP4, FLT3, HMGCR, HSD11B2, HSD17B2, IDO1, IGF1R, KDR, MMP2, MMP9, MPO, PPARA, PTGS2, RORC, SRC, TYR | 8.13569 |
[BP] GO:0055114 | oxidation-reduction process | AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, MAOA, MPO, PHF8, PTGS2, TBXAS1, TYR, XDH | 8.13501 |
[BP] GO:0006629 | lipid metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, ESR1, FABP3, FABP4, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MET, PPARA, PTGS2, TBXAS1 | 7.95375 |
[BP] GO:0032502 | developmental process | ACHE, ADORA1, AKR1B1, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CBR1, CDC25B, CDK6, CHRM1, CHRM2, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DYRK1A, DYRK1B, DYRK3, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, GLO1, HMGCR, HSD11B1, HSD17B2, KDR, MET, MMP2, MMP9, MPO, PHF8, PIM1, PPARA, PTGS2, RORC, SRC, TNKS2, TOP2A, TYR | 7.70862 |
[BP] GO:0043067 | regulation of programmed cell death | ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, DYRK3, ESR1, F3, FLT3, GLO1, HCAR2, HMGCR, IDO1, IGF1R, KDR, MET, MMP9, MPO, PIM1, PTGS2, PTPN1, SRC, TOP2A, XDH | 7.31184 |
[BP] GO:0014070 | response to organic cyclic compound | ALPL, APEX1, BCL2, CA2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FLT3, HSD11B2, PTGS2, RORC, SRC, TYR | 7.31184 |
[BP] GO:0010941 | regulation of cell death | ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, DYRK3, ESR1, F3, FLT3, GLO1, HCAR2, HMGCR, IDO1, IGF1R, KDR, MET, MMP9, MPO, PIM1, PPARA, PTGS2, PTPN1, SRC, TOP2A, XDH | 7.31184 |
[BP] GO:0042493 | response to drug | ABCG2, AKR1B1, APEX1, AXL, BCL2, CA3, CA9, CDK6, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, FABP3, HMGCR, HSD11B2, KDR, PTGS2, SRC | 7.22592 |
[BP] GO:0008202 | steroid metabolic process | AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 7.19669 |
[BP] GO:0032228 | regulation of synaptic transmission, GABAergic | ADORA1, CA2, CA7, CNR1, CNR2, DRD2, NISCH | 7.15339 |
[BP] GO:0048522 | positive regulation of cellular process | ACHE, ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CHRM1, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HCAR2, HMGCR, HTR6, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, XDH | 7.09936 |
[BP] GO:0065008 | regulation of biological quality | ABCG2, ACHE, ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CA12, CA2, CA7, CDK6, CHRM1, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, F3, FABP3, FABP4, FLT3, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KDR, MAOA, MET, NISCH, PPARA, PTGS2, SRC, TNKS, TNKS2, XDH | 7.01312 |
[BP] GO:0042981 | regulation of apoptotic process | ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, DYRK3, ESR1, F3, FLT3, GLO1, HCAR2, HMGCR, IDO1, IGF1R, KDR, MMP9, MPO, PIM1, PTGS2, PTPN1, SRC, TOP2A, XDH | 6.79126 |
[BP] GO:0009636 | response to toxic substance | AKR1B1, ALPL, APEX1, AXL, BCL2, CA3, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, HMGCR, KDR, SRC | 6.69079 |
[BP] GO:0032844 | regulation of homeostatic process | ADORA1, AURKB, BCL2, CA2, CA7, CDK6, CNR1, DRD1, DRD2, HCAR2, HMGCR, KDR, PTGS2, SRC, TNKS, TNKS2 | 6.67295 |
[BP] GO:0018108 | peptidyl-tyrosine phosphorylation | AXL, CLK1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, IGF1R, KDR, MET, SRC | 6.37999 |
[BP] GO:0018212 | peptidyl-tyrosine modification | AXL, CLK1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, IGF1R, KDR, MET, SRC | 6.31744 |
[BP] GO:0019748 | secondary metabolic process | AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR | 5.80172 |
[BP] GO:0048518 | positive regulation of biological process | ACHE, ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CHRM1, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HCAR2, HMGCR, HTR6, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, XDH | 5.73936 |
[BP] GO:0071704 | organic substance metabolic process | ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CBR1, CDC25B, CDK6, CHRM1, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HASPIN, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, MAOA, MET, MMP1, MMP12, MMP2, MMP9, MPO, NISCH, PHF8, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TBXAS1, TNKS, TNKS2, TOP2A, TYR, XDH | 5.72392 |
[BP] GO:0006796 | phosphate-containing compound metabolic process | ACHE, ALPL, APEX1, AURKB, AXL, BCL2, CA3, CDC25B, CDK6, CLK1, CSNK2A1, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, HMGCR, IGF1R, KDR, MET, PIM1, PTGS2, PTPN1, SRC, TNKS, XDH | 5.72392 |
[BP] GO:0006468 | protein phosphorylation | AURKB, AXL, BCL2, CDC25B, CDK6, CLK1, CSNK2A1, DRD1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, MET, PIM1, SRC, TNKS | 5.62654 |
[BP] GO:0015711 | organic anion transport | CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, FABP3, PPARA | 5.60649 |
[BP] GO:0060548 | negative regulation of cell death | ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, DYRK3, GLO1, HMGCR, IDO1, IGF1R, KDR, MET, MMP9, MPO, PIM1, PPARA, PTGS2, PTPN1, SRC | 5.53854 |
[BP] GO:0042127 | regulation of cell proliferation | ADORA1, ADORA3, AKR1B1, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, CYP1B1, DRD2, ESR1, ESRRA, F3, FABP3, FLT3, HMGCR, IDO1, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PTGS2, SRC, XDH | 5.48808 |
[BP] GO:0010817 | regulation of hormone levels | ACHE, ADORA1, AKR1B1, CNR1, CYP19A1, CYP1A1, CYP1B1, DRD2, ESR1, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 5.46596 |
[BP] GO:0010647 | positive regulation of cell communication | ADORA1, AKR1B1, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F3, FLT3, HCAR2, HMGCR, HTR6, KDR, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH | 5.44181 |
[BP] GO:0043069 | negative regulation of programmed cell death | ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, DYRK3, GLO1, HMGCR, IDO1, IGF1R, KDR, MET, MMP9, MPO, PIM1, PTGS2, PTPN1, SRC | 5.44181 |
[BP] GO:0023056 | positive regulation of signaling | ADORA1, AKR1B1, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F3, FLT3, HCAR2, HMGCR, HTR6, KDR, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH | 5.41875 |
[BP] GO:0006793 | phosphorus metabolic process | ACHE, ALPL, APEX1, AURKB, AXL, BCL2, CA3, CDC25B, CDK6, CLK1, CSNK2A1, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, HMGCR, IGF1R, KDR, MET, PIM1, PTGS2, PTPN1, SRC, TNKS, XDH | 5.36269 |
[BP] GO:0042445 | hormone metabolic process | ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 5.36269 |
[BP] GO:0040012 | regulation of locomotion | ADORA1, ADORA3, APEX1, BCL2, CDK6, CHRM1, CHRM4, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MMP9, NISCH, PTGS2, SRC | 5.30762 |
[BP] GO:0048523 | negative regulation of cellular process | ACHE, ADORA1, ADORA3, AKR1B1, APEX1, AURKB, AXL, BCL2, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DYRK1A, DYRK3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, HMGCR, IDO1, IGF1R, KDR, MET, MMP12, MMP9, MPO, NISCH, PHF8, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, XDH | 5.24466 |
[BP] GO:0044238 | primary metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CBR1, CDC25B, CDK6, CHRM1, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HASPIN, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NISCH, PHF8, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TBXAS1, TNKS, TNKS2, TOP2A, TYR, XDH | 5.24466 |
[BP] GO:1901564 | organonitrogen compound metabolic process | ABCG2, ACHE, AKR1B1, ALPL, AOX1, AURKB, AXL, BCL2, CDC25B, CDK6, CHRM1, CLK1, CSNK2A1, CYP1A1, CYP1A2, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, F3, FLT3, FUT7, GBA2, GLO1, HASPIN, HMGCR, IDO1, IGF1R, KDR, MAOA, MET, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PPARA, PTGS2, PTPN1, SRC, TNKS, TNKS2, TOP2A, TYR, XDH | 5.24466 |
[BP] GO:0010035 | response to inorganic substance | AKR1B1, APEX1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, MMP9, PTGS2, SRC | 5.18219 |
[BP] GO:0009725 | response to hormone | AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, PPARA, PTGS2, SRC | 4.92162 |
[BP] GO:0043066 | negative regulation of apoptotic process | ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, DYRK3, GLO1, HMGCR, IDO1, IGF1R, KDR, MMP9, MPO, PIM1, PTGS2, PTPN1, SRC | 4.88168 |
[BP] GO:0010646 | regulation of cell communication | ACHE, ADORA1, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DYRK1A, DYRK2, DYRK3, ESR1, ESR2, F3, FLT3, HCAR2, HMGCR, HTR6, IGF1R, KDR, MET, MMP12, MMP9, NISCH, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH | 4.86207 |
[BP] GO:0048519 | negative regulation of biological process | ACHE, ADORA1, ADORA3, AKR1B1, APEX1, AURKB, AXL, BCL2, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DYRK1A, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, HCAR2, HMGCR, IDO1, IGF1R, KDR, MET, MMP12, MMP9, MPO, NISCH, PHF8, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, XDH | 4.83106 |
[BP] GO:0018193 | peptidyl-amino acid modification | AURKB, AXL, BCL2, CLK1, CSNK2A1, DRD1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, MET, SRC, TNKS, TOP2A | 4.73317 |
[BP] GO:0009719 | response to endogenous stimulus | AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DRD1, ESR1, ESRRA, FABP3, FLT3, HSD11B2, IGF1R, MMP2, PPARA, PTGS2, SRC | 4.72576 |
[BP] GO:0008284 | positive regulation of cell proliferation | AKR1B1, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, DRD2, ESR1, F3, FLT3, HMGCR, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PTGS2 | 4.69952 |
[BP] GO:0032846 | positive regulation of homeostatic process | AURKB, CA2, CA7, CNR1, DRD1, DRD2, HCAR2, PTGS2, TNKS, TNKS2 | 4.67524 |
[BP] GO:0050896 | response to stimulus | ABCG2, ACHE, ADORA1, ADORA3, AKR1B1, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA3, CA6, CA9, CDK6, CHRM2, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DYRK2, ESR1, ESRRA, F3, FABP3, FABP4, FLT3, HMGCR, HSD11B2, HSD17B2, IDO1, IGF1R, KDR, MMP12, MMP2, MMP9, MPO, PPARA, PTGS2, PTPN1, RORC, SRC, TOP2A, TYR | 4.59619 |
[BP] GO:0023051 | regulation of signaling | ACHE, ADORA1, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DYRK1A, DYRK2, DYRK3, ESR1, ESR2, F3, FLT3, HCAR2, HMGCR, HTR6, IGF1R, KDR, MET, MMP12, MMP9, NISCH, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH | 4.55941 |
[BP] GO:0032501 | multicellular organismal process | ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AXL, BCL2, CHRM1, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRB, F3, FABP4, HMGCR, HSD11B2, HSD17B2, IDO1, IGF1R, MET, MMP1, MMP12, MMP2, MMP9, MPO, PIM1, PPARA, PTGS2, RORC, SRC, TNKS2, TYR | 4.51657 |
[BP] GO:2000145 | regulation of cell motility | ADORA1, ADORA3, APEX1, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MMP9, NISCH, PTGS2, SRC | 4.45395 |
[BP] GO:0007187 | None | ADORA1, CHRM1, CHRM2, CHRM4, CNR1, CNR2, DRD1, DRD2, HTR6 | 4.44372 |
[BP] GO:0006820 | anion transport | CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, FABP3, PPARA | 4.43989 |
[BP] GO:0048856 | anatomical structure development | ACHE, ADORA1, AKR1B1, ALPL, AXL, BCL2, CA2, CDK6, CHRM1, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DYRK1A, DYRK1B, ESR1, ESRRA, ESRRB, FLT3, GBA2, HSD11B1, HSD17B2, KDR, MMP9, PHF8, PIM1, PPARA, PTGS2, RORC, SRC, TYR | 4.42742 |
[BP] GO:0016310 | phosphorylation | AURKB, AXL, BCL2, CDC25B, CDK6, CLK1, CSNK2A1, DRD1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, MET, PIM1, SRC, TNKS | 4.42064 |
[BP] GO:0019369 | arachidonic acid metabolic process | CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS2, TBXAS1 | 4.41907 |
[BP] GO:0044255 | cellular lipid metabolic process | ACHE, AKR1B10, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP3, FABP4, FUT7, GBA2, HMGCR, MET, PPARA, PTGS2, TBXAS1 | 4.22633 |
[BP] GO:0046777 | protein autophosphorylation | AURKB, CLK1, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, PIM1, SRC | 4.22539 |
[BP] GO:0033559 | unsaturated fatty acid metabolic process | ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS2, TBXAS1 | 4.19078 |
[BP] GO:0030334 | regulation of cell migration | ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MMP9, NISCH, PTGS2, SRC | 4.13423 |
[BP] GO:0042446 | hormone biosynthetic process | AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 4.1312 |
[BP] GO:1901615 | organic hydroxy compound metabolic process | AKR1B1, AKR1B10, BCL2, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, GBA2, HMGCR, MAOA, TYR | 4.11671 |
[BP] GO:0032847 | regulation of cellular pH reduction | BCL2, CA2, CA7 | 4.09792 |
[BP] GO:0080134 | regulation of response to stress | ADORA1, CDK6, CNR1, CNR2, CYP19A1, DRD2, DYRK1A, DYRK3, ESR1, F3, FABP4, HMGCR, IDO1, IGF1R, MET, MMP12, MMP2, PPARA, PTGS2, PTPN1, SRC, XDH | 4.07952 |
[BP] GO:0032101 | regulation of response to external stimulus | ADORA1, CNR1, CNR2, CYP19A1, DRD1, DRD2, ESR1, F3, FABP4, HMGCR, IDO1, KDR, MET, MMP12, PPARA, PTGS2 | 4.07497 |
[BP] GO:0051270 | regulation of cellular component movement | ADORA1, ADORA3, APEX1, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MMP9, NISCH, PTGS2, SRC | 4.03666 |
[BP] GO:0050805 | negative regulation of synaptic transmission | ACHE, ADORA1, CNR2, DRD1, DRD2, PTGS2 | 4.03666 |
[BP] GO:0006690 | icosanoid metabolic process | ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS2, TBXAS1 | 4.02817 |
[BP] GO:0032496 | response to lipopolysaccharide | ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, IDO1, MPO, PTGS2, SRC | 3.99954 |
[BP] GO:0048585 | negative regulation of response to stimulus | ADORA1, BCL2, CDK6, CNR1, CNR2, CYP19A1, DRD1, DRD2, DYRK1A, DYRK3, ESR1, ESR2, HMGCR, IGF1R, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, SRC, XDH | 3.99297 |
[BP] GO:1902532 | negative regulation of intracellular signal transduction | BCL2, DRD2, DYRK1A, DYRK3, ESR1, HMGCR, IGF1R, MET, MMP9, PTGS2, PTPN1, SRC, XDH | 3.96938 |
[BP] GO:0034754 | cellular hormone metabolic process | AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 | 3.93714 |
[BP] GO:0048511 | rhythmic process | AXL, BCL2, CSNK2A1, DRD2, DYRK1A, ESR1, PPARA, RORC, SRC, TOP2A | 3.92105 |
[BP] GO:0017144 | drug metabolic process | ACHE, AKR1B1, AKR1B10, AOX1, CBR1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, IDO1, MAOA, MPO | 3.87853 |
[BP] GO:0042180 | None | AKR1B1, AKR1B10, CYP19A1, GLO1, HMGCR, IDO1 | 3.87771 |
[BP] GO:0032879 | regulation of localization | ACHE, ADORA1, ADORA3, APEX1, AXL, BCL2, CA2, CA7, CDK6, CHRM1, CNR1, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DYRK2, F3, HCAR2, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, NISCH, PPARA, PTGS2, PTPN1, SRC | 3.87395 |
[BP] GO:0019216 | regulation of lipid metabolic process | ADORA1, CNR1, CYP1A1, FABP3, FLT3, HCAR2, HMGCR, PPARA, PTGS2, RORC, SRC | 3.87003 |
[BP] GO:0044092 | negative regulation of molecular function | ADORA3, AURKB, CNR1, CNR2, CSNK2A1, CYP1B1, DRD2, ESR1, FABP4, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC, TNKS | 3.78359 |
[BP] GO:0002237 | response to molecule of bacterial origin | ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, IDO1, MPO, PTGS2, SRC | 3.78359 |
[BP] GO:0007197 | None | CHRM1, CHRM2, CHRM4 | 3.78359 |
[BP] GO:0009987 | cellular process | ABCG2, ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CDK6, CHRM1, CHRM2, CHRM4, CLK1, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HASPIN, HCAR2, HMGCR, HSD17B1, HSD17B2, HTR6, IDO1, IGF1R, KDR, MAOA, MET, MMP1, MMP12, MMP2, MMP9, MPO, NISCH, PHF8, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TBXAS1, TNKS, TNKS2, TOP2A, TYR, XDH | 3.73488 |
[BP] GO:0050804 | modulation of chemical synaptic transmission | ACHE, ADORA1, CA2, CA7, CNR1, CNR2, DRD1, DRD2, NISCH, PTGS2 | 3.73364 |
[BP] GO:0099177 | regulation of trans-synaptic signaling | ACHE, ADORA1, CA2, CA7, CNR1, CNR2, DRD1, DRD2, NISCH, PTGS2 | 3.73364 |
[BP] GO:1902531 | regulation of intracellular signal transduction | ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DYRK1A, DYRK2, DYRK3, ESR1, F3, FLT3, HMGCR, HTR6, IGF1R, KDR, MET, MMP9, PTGS2, PTPN1, SRC, XDH | 3.72933 |
[BP] GO:0048513 | animal organ development | ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, KDR, PHF8, PPARA, SRC, TYR | 3.70244 |
[BP] GO:0030522 | intracellular receptor signaling pathway | ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, RORC, SRC | 3.65888 |
[BP] GO:0018107 | peptidyl-threonine phosphorylation | BCL2, CLK1, CSNK2A1, DYRK1A, HASPIN, TNKS | 3.61979 |
[BP] GO:0018958 | None | AKR1B1, BCL2, DRD1, DRD2, MAOA, TYR | 3.61979 |
[BP] GO:0010243 | response to organonitrogen compound | AKR1B1, APEX1, CNR1, CNR2, DRD1, DRD2, FABP3, FLT3, HSD11B2, IGF1R, MMP2, PPARA, PTGS2, SRC, TYR | 3.61369 |
[BP] GO:0032787 | None | ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, GBA2, GLO1, IDO1, PPARA, PTGS2, TBXAS1 | 3.5791 |
[BP] GO:0006694 | steroid biosynthetic process | AKR1B1, CYP19A1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 3.56553 |
[BP] GO:0007207 | None | CHRM1, CHRM2, CHRM4 | 3.53346 |
[BP] GO:0031325 | positive regulation of cellular metabolic process | ADORA1, AURKB, BCL2, CDC25B, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PHF8, PPARA, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, XDH | 3.52762 |
[BP] GO:0010604 | positive regulation of macromolecule metabolic process | ADORA1, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PHF8, PPARA, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, XDH | 3.49436 |
[BP] GO:0043401 | steroid hormone mediated signaling pathway | ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC | 3.48777 |
[BP] GO:0048583 | regulation of response to stimulus | ADORA1, AKR1B1, AURKB, AXL, BCL2, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DYRK1A, DYRK2, DYRK3, ESR1, ESR2, ESRRA, F3, FABP4, FLT3, HMGCR, HTR6, IDO1, IGF1R, KDR, MET, MMP12, MMP2, MMP9, PPARA, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH | 3.48383 |
[BP] GO:0048584 | positive regulation of response to stimulus | ADORA1, AKR1B1, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, DRD2, ESRRA, F3, FABP4, FLT3, HMGCR, HTR6, IDO1, KDR, MET, MMP12, MMP2, MMP9, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH | 3.4747 |
[BP] GO:0018210 | peptidyl-threonine modification | BCL2, CLK1, CSNK2A1, DYRK1A, HASPIN, TNKS | 3.43273 |
[BP] GO:0001666 | response to hypoxia | ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2, SRC | 3.39839 |
[BP] GO:0051173 | positive regulation of nitrogen compound metabolic process | ADORA1, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DYRK1A, DYRK1B, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PHF8, PPARA, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, XDH | 3.38289 |
[BP] GO:0007200 | None | CHRM1, CHRM2, CHRM4, DRD1, DRD2, ESR1 | 3.38289 |
[BP] GO:0009967 | positive regulation of signal transduction | ADORA1, AKR1B1, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, F3, FLT3, HMGCR, HTR6, KDR, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH | 3.37656 |
[BP] GO:0036293 | response to decreased oxygen levels | ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2, SRC | 3.30588 |
[BP] GO:0006979 | response to oxidative stress | AKR1B1, APEX1, AXL, BCL2, CA3, CYP1B1, MMP9, MPO, PTGS2, SRC | 3.30459 |
[BP] GO:0010648 | negative regulation of cell communication | ACHE, ADORA1, BCL2, CNR2, DRD1, DRD2, DYRK1A, DYRK3, ESR1, ESR2, HMGCR, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, XDH | 3.27487 |
[BP] GO:1901698 | response to nitrogen compound | AKR1B1, APEX1, CNR1, CNR2, DRD1, DRD2, FABP3, FLT3, HSD11B2, IGF1R, MMP2, PPARA, PTGS2, SRC, TYR | 3.2612 |
[BP] GO:0023057 | negative regulation of signaling | ACHE, ADORA1, BCL2, CNR2, DRD1, DRD2, DYRK1A, DYRK3, ESR1, ESR2, HMGCR, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, XDH | 3.2612 |
[BP] GO:0009991 | response to extracellular stimulus | ALPL, AXL, BCL2, CNR1, CYP1A1, HMGCR, HSD11B2, MPO, PTGS2, SRC, TYR | 3.25523 |
[BP] GO:0008210 | estrogen metabolic process | CYP19A1, CYP1B1, HSD17B1, HSD17B2 | 3.25456 |
[BP] GO:1903409 | reactive oxygen species biosynthetic process | CYP1A1, CYP1A2, CYP1B1, MPO | 3.25456 |
[BP] GO:0032845 | None | ADORA1, BCL2, DRD2, HMGCR, SRC, TNKS, TNKS2 | 3.24408 |
[BP] GO:0071407 | cellular response to organic cyclic compound | ALPL, APEX1, CYP1A1, CYP1B1, DRD1, ESR1, FLT3, PTGS2, RORC, SRC | 3.23945 |
[BP] GO:0009893 | positive regulation of metabolic process | ADORA1, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PHF8, PPARA, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, XDH | 3.21525 |
[BP] GO:0009056 | catabolic process | ACHE, ADORA1, AKR1B10, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, GBA2, IDO1, MAOA, MMP1, MMP12, MMP2, MMP9, MPO, SRC, XDH | 3.206 |
[BP] GO:2000021 | regulation of ion homeostasis | ADORA1, BCL2, CA2, CA7, DRD1, DRD2, KDR, SRC | 3.20352 |
[BP] GO:0008217 | None | ADORA1, CNR1, DRD2, HSD11B2, NISCH, PPARA, PTGS2 | 3.16302 |
[BP] GO:0035690 | cellular response to drug | AKR1B1, APEX1, AXL, CDK6, CYP1B1, DRD1, KDR, PTGS2, SRC | 3.15644 |
[BP] GO:0006082 | organic acid metabolic process | ABCG2, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, GBA2, GLO1, IDO1, MPO, PIM1, PPARA, PTGS2, TBXAS1, TYR | 3.10305 |
[BP] GO:0001676 | long-chain fatty acid metabolic process | CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS2, TBXAS1 | 3.09396 |
[BP] GO:1901568 | fatty acid derivative metabolic process | ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS2, TBXAS1 | 3.06907 |
[BP] GO:0070482 | response to oxygen levels | ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2, SRC | 3.0651 |
[BP] GO:0007188 | None | ADORA1, CHRM1, CHRM2, CHRM4, CNR1, DRD1, DRD2 | 3.05703 |
[BP] GO:1902533 | positive regulation of intracellular signal transduction | ADORA1, AKR1B1, AXL, BCL2, CYP1B1, DRD2, F3, FLT3, HMGCR, HTR6, KDR, MET, PTGS2, PTPN1, SRC, XDH | 3.05703 |
[BP] GO:0071310 | cellular response to organic substance | AKR1B1, ALPL, APEX1, AXL, BCL2, CDK6, CYP1A1, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, PTGS2, RORC, SRC | 3.05681 |
[BP] GO:0034502 | protein localization to chromosome | AURKB, ESR1, HASPIN, TNKS, TNKS2 | 3.05598 |
[BP] GO:0051966 | regulation of synaptic transmission, glutamatergic | ADORA1, CNR1, DRD1, DRD2, PTGS2 | 3.05598 |
[BP] GO:0008283 | cell proliferation | ACHE, AURKB, BCL2, CHRM1, CHRM4, CLK1, CYP1A1, ESR1, FLT3, MET, PIM1, SRC, TYR | 3.04182 |
[BP] GO:0006631 | fatty acid metabolic process | ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA, PTGS2, TBXAS1 | 3.02367 |
[BP] GO:0070887 | cellular response to chemical stimulus | AKR1B1, ALPL, APEX1, AXL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, PTGS2, RORC, SRC | 3.01189 |
[BP] GO:0022414 | reproductive process | AKR1B1, ALPL, AXL, BCL2, CDC25B, CNR1, CYP19A1, CYP1A1, DRD1, ESR1, ESRRB, HSD11B2, HSD17B2, IDO1, MMP2, MMP9, PTGS2, SRC, TOP2A | 3.00806 |
[BP] GO:0042542 | response to hydrogen peroxide | AKR1B1, APEX1, AXL, BCL2, CYP1B1, SRC | 2.94448 |
[BP] GO:0034614 | cellular response to reactive oxygen species | AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC | 2.94448 |
[BP] GO:0009628 | response to abiotic stimulus | ADORA1, AKR1B1, AURKB, BCL2, CA2, CYP1A1, DRD1, DRD2, HMGCR, HSD11B2, MMP2, MPO, PPARA, PTGS2, SRC, TYR | 2.94134 |
[BP] GO:0007568 | aging | APEX1, AURKB, BCL2, CNR1, CYP1A1, HMGCR, MPO, PTGS2 | 2.93657 |
[BP] GO:0018105 | peptidyl-serine phosphorylation | AURKB, BCL2, CLK1, DRD1, DYRK1A, SRC, TNKS | 2.93657 |
[BP] GO:0097267 | omega-hydroxylase P450 pathway | CYP1A1, CYP1A2, CYP1B1 | 2.91657 |
[BP] GO:0009755 | hormone-mediated signaling pathway | ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC | 2.91657 |
[BP] GO:0031347 | regulation of defense response | ADORA1, CNR1, CNR2, CYP19A1, DRD2, ESR1, FABP4, IDO1, MMP12, MMP2, PPARA, PTGS2, PTPN1, SRC | 2.89963 |
[BP] GO:0009891 | positive regulation of biosynthetic process | AURKB, DRD1, DRD2, DYRK1B, DYRK2, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, KDR, MET, MMP12, PHF8, PPARA, PTGS2, RORC, SRC, TNKS, TNKS2, TOP2A | 2.85118 |
[BP] GO:0000302 | response to reactive oxygen species | AKR1B1, APEX1, AXL, BCL2, CYP1B1, MMP9, SRC | 2.80741 |
[BP] GO:0031667 | response to nutrient levels | ALPL, BCL2, CNR1, CYP1A1, HMGCR, HSD11B2, MPO, PTGS2, SRC, TYR | 2.79808 |
[BP] GO:0019371 | None | CBR1, PTGS2, TBXAS1 | 2.7948 |
[BP] GO:0010907 | None | DYRK2, ESRRB, PPARA, SRC | 2.7948 |
[BP] GO:0043207 | response to external biotic stimulus | ALPL, AXL, BCL2, CDK6, CHRM2, CNR1, CNR2, CYP1A1, CYP1A2, IDO1, MMP12, MPO, PTGS2, SRC | 2.78525 |
[BP] GO:0043065 | positive regulation of apoptotic process | BCL2, CNR1, CYP1B1, F3, HCAR2, HMGCR, IDO1, MMP9, PTGS2, SRC, TOP2A, XDH | 2.71 |
[BP] GO:0050806 | positive regulation of synaptic transmission | ADORA1, CA2, CA7, DRD1, DRD2, PTGS2 | 2.70371 |
[BP] GO:0021885 | forebrain cell migration | AXL, DRD1, DRD2, HTR6 | 2.69963 |
[BP] GO:0097164 | None | ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2, MAOA | 2.69889 |
[BP] GO:0043068 | positive regulation of programmed cell death | BCL2, CNR1, CYP1B1, F3, HCAR2, HMGCR, IDO1, MMP9, PTGS2, SRC, TOP2A, XDH | 2.67666 |
[BP] GO:0018209 | peptidyl-serine modification | AURKB, BCL2, CLK1, DRD1, DYRK1A, SRC, TNKS | 2.67262 |
[BP] GO:0009115 | None | AOX1, XDH | 2.66733 |
[BP] GO:0043436 | oxoacid metabolic process | ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, GBA2, GLO1, IDO1, MPO, PIM1, PPARA, PTGS2, TBXAS1, TYR | 2.65954 |
[BP] GO:0009607 | response to biotic stimulus | ALPL, AXL, BCL2, CDK6, CHRM2, CNR1, CNR2, CYP1A1, CYP1A2, IDO1, MMP12, MPO, PTGS2, SRC | 2.60711 |
[BP] GO:0007193 | None | ADORA1, CHRM1, CHRM2, CHRM4, DRD2 | 2.60517 |
[BP] GO:0048661 | positive regulation of smooth muscle cell proliferation | AKR1B1, HMGCR, MMP2, MMP9, PTGS2 | 2.60517 |
[BP] GO:0006703 | estrogen biosynthetic process | CYP19A1, HSD17B1, HSD17B2 | 2.59632 |
[BP] GO:0048869 | cellular developmental process | ACHE, ALPL, AXL, BCL2, CBR1, CDC25B, CDK6, CYP1A1, DRD1, DRD2, DYRK3, ESR1, ESRRB, FABP4, FLT3, FUT7, GBA2, GLO1, HMGCR, KDR, MET, MMP2, MMP9, PTGS2, RORC, SRC, TOP2A | 2.58497 |
[BP] GO:0030336 | None | ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2, NISCH | 2.57739 |
[BP] GO:0007165 | signal transduction | ADORA1, ADORA3, AKR1B1, AXL, BCL2, CA1, CA2, CDK6, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CSNK2A1, CYP1B1, DRD1, DRD2, DYRK2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HASPIN, HCAR2, HTR6, IGF1R, KDR, MET, MMP2, MMP9, NISCH, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2 | 2.53915 |
[BP] GO:0019752 | carboxylic acid metabolic process | ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, GBA2, GLO1, IDO1, PIM1, PPARA, PTGS2, TBXAS1, TYR | 2.53795 |
[BP] GO:0016042 | lipid catabolic process | ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, GBA2 | 2.52956 |
[BP] GO:0042592 | homeostatic process | ABCG2, ADORA1, AKR1B1, APEX1, AXL, BCL2, CA12, CA2, CA7, CNR1, DRD1, DRD2, ESR1, FABP3, FABP4, FLT3, MET, SRC | 2.51913 |
[BP] GO:0060065 | uterus development | CYP19A1, ESR1, SRC | 2.51321 |
[BP] GO:1901701 | cellular response to oxygen-containing compound | AKR1B1, APEX1, AXL, CDK6, CYP1B1, DRD1, ESR1, IGF1R, MMP2, MMP9, PTGS2, RORC, SRC | 2.50438 |
[BP] GO:0031328 | positive regulation of cellular biosynthetic process | AURKB, DRD1, DRD2, DYRK1B, DYRK2, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, MET, MMP12, PHF8, PPARA, PTGS2, RORC, SRC, TNKS, TNKS2, TOP2A | 2.50302 |
[BP] GO:0008610 | lipid biosynthetic process | ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, PTGS2 | 2.44103 |
[BP] GO:0045776 | None | ADORA1, CNR1, DRD2, PPARA | 2.44103 |
[BP] GO:2000146 | None | ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2, NISCH | 2.43876 |
[BP] GO:0010942 | positive regulation of cell death | BCL2, CNR1, CYP1B1, F3, HCAR2, HMGCR, IDO1, MMP9, PTGS2, SRC, TOP2A, XDH | 2.42355 |
[BP] GO:0006584 | None | AKR1B1, DRD1, DRD2, MAOA | 2.41395 |
[BP] GO:0009712 | None | AKR1B1, DRD1, DRD2, MAOA | 2.41395 |
[BP] GO:0043271 | negative regulation of ion transport | ADORA1, BCL2, CNR1, DRD2, MMP9, PTGS2 | 2.40722 |
[BP] GO:0009605 | response to external stimulus | ADORA1, ALPL, AXL, BCL2, CDK6, CHRM2, CNR1, CNR2, CYP1A1, CYP1A2, HMGCR, HSD11B2, IDO1, MMP12, MPO, PTGS2, SRC, TYR | 2.38627 |
[BP] GO:0007213 | None | CHRM1, CHRM2, CHRM4 | 2.36674 |
[BP] GO:0030540 | female genitalia development | AXL, CYP19A1, ESR1 | 2.36674 |
[BP] GO:0032225 | None | DRD1, DRD2, PTGS2 | 2.36674 |
[BP] GO:0065007 | biological regulation | ABCG2, ACHE, ADORA1, ADORA3, AKR1B1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CA9, CDC25B, CDK6, CHRM1, CHRM2, CHRM4, CLK1, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, HASPIN, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR6, IDO1, IGF1R, KDR, MAOA, MET, MMP1, MMP12, MMP2, MMP9, MPO, NISCH, PHF8, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, XDH | 2.34053 |
[BP] GO:0051271 | None | ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2, NISCH | 2.29614 |
[BP] GO:1904355 | positive regulation of telomere capping | AURKB, TNKS, TNKS2 | 2.29279 |
[BP] GO:0048545 | response to steroid hormone | ALPL, BCL2, CA2, FLT3, HSD11B2, PTGS2, SRC | 2.28193 |
[BP] GO:0046110 | None | AOX1, XDH | 2.28193 |
[BP] GO:0032849 | positive regulation of cellular pH reduction | CA2, CA7 | 2.28193 |
[BP] GO:0033602 | None | CNR1, DRD2 | 2.28193 |
[BP] GO:0009892 | negative regulation of metabolic process | ADORA1, APEX1, AURKB, BCL2, CNR1, CNR2, CSNK2A1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, FABP4, HCAR2, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, XDH | 2.26728 |
[BP] GO:0050727 | regulation of inflammatory response | ADORA1, CNR1, CNR2, CYP19A1, ESR1, FABP4, IDO1, PPARA, PTGS2 | 2.26728 |
[BP] GO:0016137 | None | AKR1B1, AKR1B10, GBA2 | 2.23335 |
[BP] GO:0090087 | None | ACHE, ADORA1, CA2, CHRM1, CNR1, DRD2, DYRK2, HCAR2, HMGCR, MMP12, PTGS2, PTPN1, SRC | 2.23335 |
[BP] GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway | BCL2, MMP9, PTGS2, PTPN1, SRC | 2.22975 |
[BP] GO:0031960 | response to corticosteroid | ALPL, BCL2, FLT3, HSD11B2, PTGS2, SRC | 2.22029 |
[BP] GO:0003018 | None | ADORA1, CHRM1, DRD1, HMGCR, PTGS2, SRC | 2.22029 |
[BP] GO:0010906 | None | DYRK2, ESRRB, PPARA, RORC, SRC | 2.21475 |
[BP] GO:0003014 | None | ADORA1, AKR1B1, BCL2, DRD2, HSD11B2 | 2.21475 |
[BP] GO:0040013 | None | ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2, NISCH | 2.18673 |
[BP] GO:0006807 | nitrogen compound metabolic process | ABCG2, ACHE, AKR1B1, AKR1B10, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CDC25B, CDK6, CHRM1, CLK1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, FUT7, GBA2, GLO1, HASPIN, HMGCR, IDO1, IGF1R, KDR, MAOA, MET, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, TYR, XDH | 2.17945 |
[BP] GO:0042752 | None | ADORA1, DRD2, PPARA, RORC, TOP2A | 2.17705 |
[BP] GO:0051900 | regulation of mitochondrial depolarization | BCL2, KDR, SRC | 2.17589 |
[BP] GO:0006367 | transcription initiation from RNA polymerase II promoter | ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC | 2.15557 |
[BP] GO:0010676 | None | DYRK2, ESRRB, PPARA, SRC | 2.14832 |
[BP] GO:0050994 | None | ADORA1, CNR1, HCAR2, PPARA | 2.14832 |
[BP] GO:0002683 | negative regulation of immune system process | ADORA1, AXL, CDK6, CNR1, CNR2, CYP19A1, DRD2, IDO1, MMP12 | 2.14832 |
[BP] GO:0022900 | electron transport chain | AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, XDH | 2.13549 |
[BP] GO:0032210 | regulation of telomere maintenance via telomerase | AURKB, SRC, TNKS, TNKS2 | 2.12053 |
[BP] GO:0010038 | response to metal ion | BCL2, CA2, CYP1A1, CYP1A2, DRD2, FABP4, MMP9, PTGS2 | 2.11984 |
[BP] GO:0072593 | reactive oxygen species metabolic process | BCL2, CYP1A1, CYP1A2, CYP1B1, MPO | 2.11382 |
[BP] GO:0051716 | cellular response to stimulus | AKR1B1, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CDK6, CYP1A1, CYP1A2, CYP1B1, DRD1, DYRK2, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, PTGS2, PTPN1, RORC, SRC, TOP2A | 2.08459 |
[BP] GO:0051239 | regulation of multicellular organismal process | ADORA1, ADORA3, AXL, BCL2, CA2, CDK6, CHRM1, CHRM2, CNR1, CYP1B1, DRD2, ESR1, ESRRA, ESRRB, F3, HCAR2, HMGCR, IDO1, KDR, MET, MMP12, MMP9, PIM1, PTGS2, SRC, TNKS2, XDH | 2.06665 |
[BP] GO:0071498 | cellular response to fluid shear stress | CA2, PTGS2, SRC | 2.06665 |
[BP] GO:0032094 | None | CYP1A1, HSD11B2, MPO | 2.06665 |
[BP] GO:0019373 | epoxygenase P450 pathway | CYP1A1, CYP1A2, CYP1B1 | 2.06665 |
[BP] GO:0010562 | positive regulation of phosphorus metabolic process | ADORA1, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP3, FLT3, HMGCR, KDR, MMP9, PTGS2, PTPN1, SRC, XDH | 2.05908 |
[BP] GO:0045937 | positive regulation of phosphate metabolic process | ADORA1, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP3, FLT3, HMGCR, KDR, MMP9, PTGS2, PTPN1, SRC, XDH | 2.05908 |
[BP] GO:0019538 | protein metabolic process | ACHE, ALPL, AURKB, AXL, BCL2, CDC25B, CDK6, CHRM1, CLK1, CSNK2A1, DRD1, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, F3, FLT3, FUT7, HASPIN, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PPARA, PTPN1, SRC, TNKS, TNKS2, TOP2A | 2.05154 |
[BP] GO:0070213 | None | TNKS, TNKS2 | 2.04813 |
[BP] GO:0006145 | None | AOX1, XDH | 2.04813 |
[BP] GO:0038171 | None | CNR1, CNR2 | 2.04813 |
[BP] GO:0018894 | dibenzo-p-dioxin metabolic process | CYP1A1, CYP1A2 | 2.04813 |
[BP] GO:0031348 | negative regulation of defense response | ADORA1, CNR2, CYP19A1, DRD2, MMP12, PPARA | 2.03725 |
[BP] GO:0010557 | positive regulation of macromolecule biosynthetic process | AURKB, DRD2, DYRK1B, DYRK2, ESR1, ESR2, ESRRA, ESRRB, IGF1R, KDR, MET, MMP12, PHF8, PPARA, RORC, SRC, TNKS, TNKS2, TOP2A | 2.02926 |
[BP] GO:0030520 | intracellular estrogen receptor signaling pathway | ESR1, ESR2, SRC | 2.02698 |
[BP] GO:0050995 | None | ADORA1, CNR1, HCAR2 | 2.02698 |
[CC] GO:0043226 | organelle | ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA2, CA4, CA5A, CA5B, CA6, CA9, CBR1, CDK6, CHRM1, CLK1, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HASPIN, HMGCR, HTR6, IDO1, IGF1R, KDR, MAOA, MMP12, MMP2, MMP9, MPO, NISCH, PHF8, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, TYR, XDH | 2.91657 |
[CC] GO:0043227 | membrane-bounded organelle | ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA2, CA4, CA5A, CA5B, CA6, CBR1, CDK6, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HASPIN, HMGCR, IGF1R, KDR, MAOA, MMP12, MMP2, MMP9, MPO, NISCH, PHF8, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, TYR, XDH | 2.62791 |
[CC] GO:0044444 | cytoplasmic part | ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, AURKB, BCL2, CA1, CA2, CA3, CA4, CA5A, CA5B, CA7, CBR1, CDC25B, CDK6, CHRM2, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DYRK2, DYRK3, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, KDR, MAOA, MMP2, MMP9, MPO, NISCH, PIM1, PTGS2, PTPN1, SRC, TBXAS1, TNKS, TNKS2, TOP2A, TYR, XDH | 2.15072 |
[CC] GO:0098590 | plasma membrane region | ABCG2, ADORA1, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, CNR1, DRD1, DRD2, MET, PTGS2, SRC | 2.05001 |
[CC] GO:0005789 | endoplasmic reticulum membrane | BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B2, PTGS2, TBXAS1 | 1.81994 |
[MF] GO:0004089 | carbonate dehydratase activity | CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 | 18.6286 |
[MF] GO:0046914 | transition metal ion binding | ALOX5, AOX1, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DYRK2, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PPARA, PTPN1, RORC, TBXAS1, TNKS, TYR, XDH | 16.967 |
[MF] GO:0003824 | catalytic activity | ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CDK6, CHRM1, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DYRK1A, DYRK1B, DYRK2, DYRK3, F3, FLT3, FUT7, GBA2, GLO1, HASPIN, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, MAOA, MET, MMP1, MMP12, MMP2, MMP9, MPO, PHF8, PIM1, PTGS2, PTPN1, SRC, TBXAS1, TNKS, TNKS2, TOP2A, TYR, XDH | 15.2334 |
[MF] GO:0043167 | ion binding | ABCG2, ACHE, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CDK6, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, HASPIN, HMGCR, HSD17B1, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, MPO, NISCH, PHF8, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TBXAS1, TNKS, TNKS2, TOP2A, TYR, XDH | 13.5765 |
[MF] GO:0016835 | carbon-oxygen lyase activity | APEX1, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 | 11.7468 |
[MF] GO:0016836 | hydro-lyase activity | CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 | 11.7029 |
[MF] GO:0016491 | oxidoreductase activity | AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, MAOA, MPO, PHF8, PTGS2, TBXAS1, TYR, XDH | 9.83199 |
[MF] GO:0008270 | zinc ion binding | CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, PHF8, PPARA, PTPN1, RORC, TNKS | 9.83199 |
[MF] GO:0016829 | lyase activity | APEX1, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, GLO1 | 8.58263 |
[MF] GO:0043169 | cation binding | ACHE, ALOX5, ALPL, AOX1, APEX1, AURKB, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, GLO1, IDO1, MMP1, MMP12, MMP2, MMP9, MPO, PHF8, PIM1, PPARA, PTGS2, PTPN1, RORC, TBXAS1, TNKS, TNKS2, TOP2A, TYR, XDH | 7.91837 |
[MF] GO:0008144 | drug binding | ABCG2, ACHE, AURKB, AXL, CDK6, CHRM1, CHRM2, CLK1, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, MET, PIM1, PPARA, SRC, TOP2A | 6.87501 |
[MF] GO:0046872 | metal ion binding | ALOX5, ALPL, AOX1, APEX1, AURKB, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, GLO1, IDO1, MMP1, MMP12, MMP2, MMP9, MPO, PHF8, PIM1, PPARA, PTGS2, PTPN1, RORC, TBXAS1, TNKS, TNKS2, TOP2A, TYR, XDH | 6.60071 |
[MF] GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | AKR1B1, AKR1B10, AOX1, CBR1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH | 6.49439 |
[MF] GO:0004713 | protein tyrosine kinase activity | AXL, CLK1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, IGF1R, KDR, MET, SRC | 6.49439 |
[MF] GO:0020037 | heme binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, IDO1, MPO, PTGS2, SRC, TBXAS1 | 5.53854 |
[MF] GO:0046906 | tetrapyrrole binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, IDO1, MPO, PTGS2, SRC, TBXAS1 | 5.32578 |
[MF] GO:0038023 | signaling receptor activity | ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM4, CNR1, CNR2, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, HTR6, IGF1R, KDR, MET, PPARA, RORC | 5.02403 |
[MF] GO:0004672 | protein kinase activity | AURKB, AXL, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, MET, PIM1, SRC | 4.96202 |
[MF] GO:0048037 | cofactor binding | AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HMGCR, HSD11B2, HSD17B1, IDO1, MPO, PTGS2, SRC, TBXAS1, XDH | 4.96202 |
[MF] GO:0004712 | protein serine/threonine/tyrosine kinase activity | AURKB, CLK1, DYRK1A, DYRK1B, DYRK2, DYRK3 | 4.95925 |
[MF] GO:0005506 | iron ion binding | ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, PHF8, TBXAS1, XDH | 4.8584 |
[MF] GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | AKR1B1, AKR1B10, CBR1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 4.71509 |
[MF] GO:0098531 | transcription factor activity, direct ligand regulated sequence-specific DNA binding | ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC | 4.61901 |
[MF] GO:0004879 | nuclear receptor activity | ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC | 4.61901 |
[MF] GO:0060089 | molecular transducer activity | ADORA1, ADORA3, AXL, CDK6, CHRM1, CHRM2, CHRM4, CNR1, CNR2, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, HTR6, IGF1R, KDR, MET, PPARA, RORC | 4.55941 |
[MF] GO:0005496 | steroid binding | ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1, RORC | 4.49669 |
[MF] GO:0004872 | receptor activity | ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM4, CNR1, CNR2, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, HTR6, IGF1R, KDR, MET, PPARA, RORC | 4.22633 |
[MF] GO:0003707 | steroid hormone receptor activity | ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC | 4.20472 |
[MF] GO:0016773 | phosphotransferase activity, alcohol group as acceptor | AURKB, AXL, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, MET, PIM1, SRC | 4.072 |
[MF] GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1, PHF8, PTGS2, TBXAS1, TYR | 3.99297 |
[MF] GO:0016907 | None | CHRM1, CHRM2, CHRM4 | 3.78359 |
[MF] GO:0016301 | kinase activity | AURKB, AXL, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, MET, PIM1, SRC | 3.65652 |
[MF] GO:0004871 | signal transducer activity | ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM4, CNR1, CNR2, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, HTR6, IGF1R, KDR, MET, PPARA, RORC | 3.62333 |
[MF] GO:0070330 | aromatase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1 | 3.30828 |
[MF] GO:0004497 | monooxygenase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, TBXAS1, TYR | 3.20408 |
[MF] GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1 | 3.13475 |
[MF] GO:0008227 | None | CHRM1, CHRM2, CHRM4, DRD2, HTR6 | 3.10403 |
[MF] GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 3.07746 |
[MF] GO:0016229 | steroid dehydrogenase activity | HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 2.98008 |
[MF] GO:0004714 | transmembrane receptor protein tyrosine kinase activity | AXL, FLT3, IGF1R, KDR, MET | 2.96428 |
[MF] GO:0009055 | electron transfer activity | AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, XDH | 2.94448 |
[MF] GO:0030594 | None | CHRM1, CHRM2, CHRM4, DRD1, DRD2, HTR6 | 2.9311 |
[MF] GO:0008289 | lipid binding | AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, HSD11B2, HSD17B1, NISCH, PPARA, RORC | 2.92028 |
[MF] GO:0016772 | transferase activity, transferring phosphorus-containing groups | AURKB, AXL, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, MET, PIM1, SRC | 2.91657 |
[MF] GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding | ESR1, ESR2 | 2.66733 |
[MF] GO:0003845 | None | HSD11B1, HSD11B2 | 2.66733 |
[MF] GO:0036094 | small molecule binding | ABCG2, ADORA1, AOX1, AURKB, AXL, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FABP3, FABP4, FLT3, HASPIN, HMGCR, HSD11B2, HSD17B1, IGF1R, KDR, MET, PIM1, SRC, TOP2A, XDH | 2.60401 |
[MF] GO:0099528 | None | CHRM1, CHRM2, CHRM4, HTR6 | 2.58497 |
[MF] GO:0019199 | transmembrane receptor protein kinase activity | AXL, FLT3, IGF1R, KDR, MET | 2.53795 |
[MF] GO:0042802 | identical protein binding | ABCG2, ACHE, AOX1, BCL2, CSNK2A1, DRD2, DYRK1A, ESR1, ESR2, FLT3, HMGCR, IGF1R, KDR, MET, MMP9, NISCH, PTGS2, TOP2A, TYR, XDH | 2.53792 |
[MF] GO:0044877 | macromolecular complex binding | ACHE, ADORA1, APEX1, CSNK2A1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, NISCH, PIM1, PPARA, PTPN1, SRC | 2.49564 |
[MF] GO:0004674 | protein serine/threonine kinase activity | AURKB, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, HASPIN, PIM1 | 2.4518 |
[MF] GO:0099600 | transmembrane receptor activity | ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM4, CNR1, CNR2, DRD1, DRD2, F3, FLT3, HCAR2, HTR6, IGF1R, KDR, MET | 2.44103 |
[MF] GO:0004888 | transmembrane signaling receptor activity | ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM4, CNR1, CNR2, DRD1, DRD2, F3, FLT3, HCAR2, HTR6, IGF1R, KDR, MET | 2.44103 |
[MF] GO:0000166 | nucleotide binding | ABCG2, AOX1, AURKB, AXL, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, HMGCR, HSD11B2, HSD17B1, IGF1R, KDR, MET, PIM1, SRC, TOP2A, XDH | 2.4282 |
[MF] GO:1901265 | nucleoside phosphate binding | ABCG2, AOX1, AURKB, AXL, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, HMGCR, HSD11B2, HSD17B1, IGF1R, KDR, MET, PIM1, SRC, TOP2A, XDH | 2.42682 |
[MF] GO:0016903 | None | AKR1B1, AKR1B10, AOX1, XDH | 2.37958 |
[MF] GO:0019825 | oxygen binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1 | 2.34791 |
[MF] GO:0032403 | protein complex binding | ACHE, ADORA1, APEX1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, NISCH, PPARA, PTPN1, SRC | 2.31503 |
[MF] GO:0004949 | None | CNR1, CNR2 | 2.28193 |
[MF] GO:0043168 | anion binding | ABCG2, AOX1, AURKB, AXL, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, F3, FABP3, FABP4, FLT3, HASPIN, HMGCR, HSD17B1, IGF1R, KDR, MET, MPO, NISCH, PIM1, SRC, TOP2A, XDH | 2.23923 |
[MF] GO:0015464 | None | CHRM1, CHRM2, CHRM4 | 2.23335 |
[MF] GO:0005524 | ATP binding | ABCG2, AURKB, AXL, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, MET, PIM1, SRC, TOP2A | 2.15466 |
[MF] GO:0140096 | catalytic activity, acting on a protein | AURKB, AXL, CDC25B, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, F3, FLT3, HASPIN, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PTPN1, SRC | 2.11811 |
[MF] GO:0032559 | adenyl ribonucleotide binding | ABCG2, AURKB, AXL, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, MET, PIM1, SRC, TOP2A | 2.0518 |
[MF] GO:0034056 | estrogen response element binding | ESR1, ESR2 | 2.04813 |
[MF] GO:0030554 | adenyl nucleotide binding | ABCG2, AURKB, AXL, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, MET, PIM1, SRC, TOP2A | 2.02926 |
KEGG Pathway ID | Enriched Genes | Log10 Adjusted P-value |
---|---|---|
Nitrogen metabolism_Homo sapiens_hsa00910 | CA12, CA1, CA5B, CA3, CA5A, CA2, CA4, CA7, CA6, CA9, CA14 | 20.0022 |
Ovarian steroidogenesis_Homo sapiens_hsa04913 | ALOX5, HSD17B1, HSD17B2, CYP1A1, CYP1B1, PTGS2, CYP19A1, IGF1R | 8.4947 |
Steroid hormone biosynthesis_Homo sapiens_hsa00140 | HSD11B1, HSD11B2, HSD17B1, HSD17B2, CYP1A2, CYP1A1, CYP1B1, CYP19A1 | 8.1303 |
Tryptophan metabolism_Homo sapiens_hsa00380 | MAOA, CYP1A2, CYP1A1, AOX1, CYP1B1, IDO1 | 6.1384 |
Metabolic pathways_Homo sapiens_hsa01100 | CBR1, MAOA, AKR1B1, HMGCR, PTGS2, TYR, GBA2, CYP19A1, HSD11B1, FUT7, AKR1B10, ALOX5, HSD17B1, TBXAS1, HSD17B2, CYP1A2, CYP1A1, AOX1, ALPL, XDH, IDO1 | 5.7929 |
Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | CHRM2, HTR6, CHRM1, CNR2, CNR1, ADORA3, CHRM4, ADORA1, DRD1, DRD2 | 5.0634 |
cAMP signaling pathway_Homo sapiens_hsa04024 | CHRM2, HCAR2, HTR6, CHRM1, ADORA1, DRD1, DRD2, PPARA | 4.3309 |
Chemical carcinogenesis_Homo sapiens_hsa05204 | HSD11B1, CBR1, CYP1A2, CYP1A1, CYP1B1, PTGS2 | 4.4847 |
Proteoglycans in cancer_Homo sapiens_hsa05205 | SRC, MMP2, KDR, MMP9, MET, ESR1, IGF1R | 3.4272 |
Pathways in cancer_Homo sapiens_hsa05200 | CDK6, FLT3, MMP1, MMP2, BCL2, PTGS2, MMP9, MET, IGF1R | 3.2125 |
Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | HSD11B1, CBR1, CYP1A2, CYP1A1, CYP1B1 | 3.5774 |
Adherens junction_Homo sapiens_hsa04520 | PTPN1, CSNK2A1, SRC, MET, IGF1R | 3.5774 |
MicroRNAs in cancer_Homo sapiens_hsa05206 | CDK6, BCL2, PIM1, CYP1B1, PTGS2, MMP9, MET, CDC25B | 3.2796 |
Cholinergic synapse_Homo sapiens_hsa04725 | CHRM2, ACHE, CHRM1, CHRM4, BCL2 | 2.9355 |
Estrogen signaling pathway_Homo sapiens_hsa04915 | SRC, MMP2, MMP9, ESR1, ESR2 | 3.1431 |
Bladder cancer_Homo sapiens_hsa05219 | SRC, MMP1, MMP2, MMP9 | 3.4272 |
Rap1 signaling pathway_Homo sapiens_hsa04015 | SRC, CNR1, KDR, DRD2, MET, IGF1R | 2.6216 |
Arachidonic acid metabolism_Homo sapiens_hsa00590 | CBR1, ALOX5, TBXAS1, PTGS2 | 2.8677 |
PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | CHRM2, CDK6, CHRM1, KDR, BCL2, MET, IGF1R | 2.3114 |
AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | MMP2, BCL2, PIM1, F3 | 2.1904 |
PPAR signaling pathway_Homo sapiens_hsa03320 | FABP3, FABP4, MMP1, PPARA | 2.7357 |
Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | FLT3, MMP9, MET, MPO, IGF1R | 2.1483 |
Serotonergic synapse_Homo sapiens_hsa04726 | HTR6, MAOA, ALOX5, PTGS2 | 2.0772 |
Focal adhesion_Homo sapiens_hsa04510 | SRC, KDR, BCL2, MET, IGF1R | 1.9944 |
Hepatitis B_Homo sapiens_hsa05161 | CDK6, SRC, BCL2, MMP9 | 1.786 |
Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | FABP4, ADORA1, PTGS2 | 1.9944 |
VEGF signaling pathway_Homo sapiens_hsa04370 | SRC, KDR, PTGS2 | 1.9087 |
Tyrosine metabolism_Homo sapiens_hsa00350 | MAOA, AOX1, TYR | 2.4735 |
Cocaine addiction_Homo sapiens_hsa05030 | MAOA, DRD1, DRD2 | 2.1188 |
Melanoma_Homo sapiens_hsa05218 | CDK6, MET, IGF1R | 1.786 |
Calcium signaling pathway_Homo sapiens_hsa04020 | CHRM2, HTR6, CHRM1, DRD1 | 1.5385 |
Prolactin signaling pathway_Homo sapiens_hsa04917 | SRC, ESR1, ESR2 | 1.786 |
Retinol metabolism_Homo sapiens_hsa00830 | CYP1A2, CYP1A1, AOX1 | 1.845 |
Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | MAOA, CYP1A2, AOX1 | 1.786 |
Bile secretion_Homo sapiens_hsa04976 | CA2, HMGCR, ABCG2 | 1.786 |
Small cell lung cancer_Homo sapiens_hsa05222 | CDK6, BCL2, PTGS2 | 1.5947 |
Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | CHRM2, CHRM1, SRC, CHRM4 | 1.3144 |
Gap junction_Homo sapiens_hsa04540 | SRC, DRD1, DRD2 | 1.5786 |
NF-kappa B signaling pathway_Homo sapiens_hsa04064 | CSNK2A1, BCL2, PTGS2 | 1.5385 |
Endocytosis_Homo sapiens_hsa04144 | SRC, KDR, MET, IGF1R | 1.0908 |
Dopaminergic synapse_Homo sapiens_hsa04728 | MAOA, DRD1, DRD2 | 1.2135 |
Sphingolipid signaling pathway_Homo sapiens_hsa04071 | ADORA3, BCL2, ADORA1 | 1.2869 |
Jak-STAT signaling pathway_Homo sapiens_hsa04630 | BCL2, PIM1, AOX1 | 1.031 |
Alcoholism_Homo sapiens_hsa05034 | MAOA, DRD1, DRD2 | 0.9359 |
Ras signaling pathway_Homo sapiens_hsa04014 | KDR, MET, IGF1R | 0.766 |
Prostate cancer_Homo sapiens_hsa05215 | BCL2, IGF1R | 0.833 |
Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | CDC25B, IGF1R | 0.7838 |
GnRH signaling pathway_Homo sapiens_hsa04912 | SRC, MMP2 | 0.833 |
Acute myeloid leukemia_Homo sapiens_hsa05221 | FLT3, PIM1 | 1.0932 |
Glioma_Homo sapiens_hsa05214 | CDK6, IGF1R | 1.0267 |
Morphine addiction_Homo sapiens_hsa05032 | ADORA1, DRD1 | 0.833 |
Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | CNR1, PTGS2 | 0.7749 |
Amphetamine addiction_Homo sapiens_hsa05031 | MAOA, DRD1 | 1.019 |
HIF-1 signaling pathway_Homo sapiens_hsa04066 | BCL2, IGF1R | 0.7667 |
Insulin resistance_Homo sapiens_hsa04931 | PTPN1, PPARA | 0.7442 |
TNF signaling pathway_Homo sapiens_hsa04668 | PTGS2, MMP9 | 0.7438 |
Central carbon metabolism in cancer_Homo sapiens_hsa05230 | FLT3, MET | 1.019 |
Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | SRC, MET | 0.9226 |
Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | FLT3, KDR, MET | 0.6847 |
Platelet activation_Homo sapiens_hsa04611 | SRC, TBXAS1 | 0.7036 |
Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | SRC, ESR1 | 0.7165 |
Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | SRC, MET | 1.0152 |
Leukocyte transendothelial migration_Homo sapiens_hsa04670 | MMP2, MMP9 | 0.7165 |
Toxoplasmosis_Homo sapiens_hsa05145 | ALOX5, BCL2 | 0.7165 |
Glycerolipid metabolism_Homo sapiens_hsa00561 | AKR1B10, AKR1B1 | 1.0872 |
AMPK signaling pathway_Homo sapiens_hsa04152 | HMGCR, IGF1R | 0.7036 |
Measles_Homo sapiens_hsa05162 | CDK6, CSNK2A1 | 0.668 |
Cell cycle_Homo sapiens_hsa04110 | CDK6, CDC25B | 0.7036 |
Parkinson's disease_Homo sapiens_hsa05012 | DRD1, DRD2 | 0.6645 |
Tight junction_Homo sapiens_hsa04530 | CSNK2A1, SRC | 0.6645 |
Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | ESRRB, IGF1R | 0.6645 |
MAPK signaling pathway_Homo sapiens_hsa04010 | CDC25B | 0.1718 |
Oxytocin signaling pathway_Homo sapiens_hsa04921 | SRC, PTGS2 | 0.6047 |
cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | ADORA3, ADORA1 | 0.5857 |
Tuberculosis_Homo sapiens_hsa05152 | SRC, BCL2 | 0.5556 |
Herpes simplex infection_Homo sapiens_hsa05168 | CSNK2A1 | 0.2496 |
Epstein-Barr virus infection_Homo sapiens_hsa05169 | CSNK2A1, BCL2 | 0.512 |
Purine metabolism_Homo sapiens_hsa00230 | XDH | 0.261 |
Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | BCL2 | 0.2699 |
Viral carcinogenesis_Homo sapiens_hsa05203 | CDK6, SRC | 0.5067 |
Chemokine signaling pathway_Homo sapiens_hsa04062 | SRC | 0.2496 |
Phagosome_Homo sapiens_hsa04145 | MPO | 0.2948 |
Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | BCL2 | 0.301 |
Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | PPARA | 0.2978 |
Apoptosis_Homo sapiens_hsa04210 | BCL2 | 0.3123 |
Insulin signaling pathway_Homo sapiens_hsa04910 | PTPN1 | 0.3123 |
Wnt signaling pathway_Homo sapiens_hsa04310 | CSNK2A1 | 0.3109 |
FoxO signaling pathway_Homo sapiens_hsa04068 | IGF1R | 0.3224 |
Hepatitis C_Homo sapiens_hsa05160 | PPARA | 0.3224 |
Axon guidance_Homo sapiens_hsa04360 | MET | 0.3311 |
Oocyte meiosis_Homo sapiens_hsa04114 | IGF1R | 0.3384 |
Neurotrophin signaling pathway_Homo sapiens_hsa04722 | BCL2 | 0.3433 |
Melanogenesis_Homo sapiens_hsa04916 | TYR | 0.3987 |
Glucagon signaling pathway_Homo sapiens_hsa04922 | PPARA | 0.3985 |
Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | SRC | 0.4024 |
Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | IGF1R | 0.407 |
Glycerophospholipid metabolism_Homo sapiens_hsa00564 | ACHE | 0.4067 |
Pancreatic secretion_Homo sapiens_hsa04972 | CA2 | 0.4064 |
ErbB signaling pathway_Homo sapiens_hsa04012 | SRC | 0.4202 |
Rheumatoid arthritis_Homo sapiens_hsa05323 | MMP1 | 0.4191 |
Hematopoietic cell lineage_Homo sapiens_hsa04640 | FLT3 | 0.4202 |
GABAergic synapse_Homo sapiens_hsa04727 | SRC | 0.4202 |
Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | CSNK2A1 | 0.4196 |
Peroxisome_Homo sapiens_hsa04146 | XDH | 0.4307 |
Chronic myeloid leukemia_Homo sapiens_hsa05220 | CDK6 | 0.467 |
Complement and coagulation cascades_Homo sapiens_hsa04610 | F3 | 0.4451 |
Leishmaniasis_Homo sapiens_hsa05140 | PTGS2 | 0.467 |
Gastric acid secretion_Homo sapiens_hsa04971 | CA2 | 0.4655 |
Adipocytokine signaling pathway_Homo sapiens_hsa04920 | PPARA | 0.4752 |
Galactose metabolism_Homo sapiens_hsa00052 | AKR1B10, AKR1B1 | 1.5388 |
p53 signaling pathway_Homo sapiens_hsa04115 | CDK6 | 0.4769 |
Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | IGF1R | 0.4897 |
Renal cell carcinoma_Homo sapiens_hsa05211 | MET | 0.4897 |
Pancreatic cancer_Homo sapiens_hsa05212 | CDK6 | 0.4897 |
Renin secretion_Homo sapiens_hsa04924 | ADORA1 | 0.4897 |
Long-term depression_Homo sapiens_hsa04730 | IGF1R | 0.4988 |
Shigellosis_Homo sapiens_hsa05131 | SRC | 0.4897 |
Colorectal cancer_Homo sapiens_hsa05210 | BCL2 | 0.4903 |
Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | RORC | 0.4897 |
Non-small cell lung cancer_Homo sapiens_hsa05223 | CDK6 | 0.513 |
Legionellosis_Homo sapiens_hsa05134 | CLK1 | 0.5158 |
Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | AKR1B10, AKR1B1 | 1.4277 |
Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | BCL2 | 0.5409 |
Malaria_Homo sapiens_hsa05144 | MET | 0.5479 |
Fructose and mannose metabolism_Homo sapiens_hsa00051 | AKR1B10, AKR1B1 | 1.5166 |
Arginine and proline metabolism_Homo sapiens_hsa00330 | MAOA | 0.5444 |
Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | ESR1 | 0.5556 |
Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | AOX1 | 0.5518 |
Drug metabolism - other enzymes_Homo sapiens_hsa00983 | XDH | 0.5556 |
Sphingolipid metabolism_Homo sapiens_hsa00600 | GBA2 | 0.5556 |
Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | HSD11B2 | 0.5933 |
ABC transporters_Homo sapiens_hsa02010 | ABCG2 | 0.5638 |
Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | CA2, CA4 | 1.731 |
Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | MAOA | 0.5924 |
African trypanosomiasis_Homo sapiens_hsa05143 | IDO1 | 0.6271 |
Pyruvate metabolism_Homo sapiens_hsa00620 | GLO1 | 0.5924 |
Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | FUT7 | 0.6645 |
Linoleic acid metabolism_Homo sapiens_hsa00591 | CYP1A2 | 0.668 |
Base excision repair_Homo sapiens_hsa03410 | APEX1 | 0.6459 |
Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | AOX1 | 0.668 |
Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | FUT7 | 0.6857 |
Circadian rhythm_Homo sapiens_hsa04710 | RORC | 0.6645 |
Collecting duct acid secretion_Homo sapiens_hsa04966 | CA2 | 0.6813 |
Histidine metabolism_Homo sapiens_hsa00340 | MAOA | 0.7036 |
Phenylalanine metabolism_Homo sapiens_hsa00360 | MAOA | 0.7749 |
Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | HMGCR | 0.7165 |
Other glycan degradation_Homo sapiens_hsa00511 | GBA2 | 0.766 |
Folate biosynthesis_Homo sapiens_hsa00790 | ALPL | 0.833 |
Caffeine metabolism_Homo sapiens_hsa00232 | CYP1A2, XDH | 2.8108 |
Vitamin B6 metabolism_Homo sapiens_hsa00750 | AOX1 | 1.0932 |